Moderna reaffirms annual COVID vaccine sales forecast

(Reuters) - Moderna on Monday reaffirmed its forecast of $6 billion to $8 billion in COVID vaccine sales for the year, after rival Pfizer slashed forecast for its vaccine last week.

Moderna said it will have "improved visibility" about the expected U.S. market size for vaccines after observing trends through October 2023.

Shares of Moderna were down about 4% in premarket trading.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Moderna (MRNA) PT Raised to $77 at Piper Sandler
• Goldman Sachs initiates FedEx Freight with Buy, sees 23% margin expansion upside
• Lionsgate content momentum boosts outlook, but debt and valuation cap upside